FDA Issues New Nitrosamine Impurities Guidance
Published:
Aug 11, 2023
On August 4, 2023, the FDA issued a new Guidance to the pharmaceutical industry relating to large molecule drugs left unaddressed in its earlier nitrosamine Guidance publications. (Access the complete Guidance or the abbreviated version.) Reacting to considerable input from the pharmaceutical industry, both brand and generic, following the agency's Federal Register...
Read More
Read More